| scholarly article | Q13442814 |
| P50 | author | Reinhold Jagsch | Q44349684 |
| P2093 | author name string | Martin Langer | |
| Annemarie Unger | |||
| Gabriele Fischer | |||
| Andjela Baewert | |||
| Kenneth Thau | |||
| Klaudia Graf-Rohrmeister | |||
| Bernadette Winklbaur-Hausknost | |||
| P2860 | cites work | Epidemiology and causes of preterm birth | Q29615799 |
| Enrolling pregnant women in research--lessons from the H1N1 influenza pandemic | Q30390398 | ||
| Neonatal abstinence syndrome after methadone or buprenorphine exposure | Q30499416 | ||
| Methadone dose and neonatal abstinence syndrome-systematic review and meta-analysis | Q33692098 | ||
| Gender issues in the pharmacotherapy of opioid-addicted women: buprenorphine | Q33807411 | ||
| Impact of treatment approach on maternal and neonatal outcome in pregnant opioid-maintained women | Q33862878 | ||
| Clinical characteristics of central European and North American samples of pregnant women screened for opioid agonist treatment. | Q34051048 | ||
| Characteristics of opioid-using pregnant women who accept or refuse participation in a clinical trial: screening results from the MOTHER study | Q34078533 | ||
| Randomized controlled trials in pregnancy: scientific and ethical aspects. Exposure to different opioid medications during pregnancy in an intra-individual comparison | Q35023911 | ||
| Use of buprenorphine in pregnancy: patient management and effects on the neonate | Q35124209 | ||
| Influence of site differences between urban and rural American and Central European opioid-dependent pregnant women and neonatal outcome characteristics. | Q36966035 | ||
| Illicit drug use and adverse birth outcomes: is it drugs or context? | Q36985301 | ||
| Treatment of opioid-dependent pregnant women: clinical and research issues | Q37076673 | ||
| Treating pregnant women dependent on opioids is not the same as treating pregnancy and opioid dependence: a knowledge synthesis for better treatment for women and neonates | Q37265588 | ||
| Maternal methadone dosing schedule and fetal neurobehaviour | Q37275955 | ||
| Higher maternal doses of methadone does not increase neonatal abstinence syndrome | Q37831536 | ||
| Cocaine use in Europe - a multi-centre study. Methodology and prevalence estimates | Q39694637 | ||
| Pregnancy under high-dose buprenorphine | Q40021165 | ||
| Preterm birth-associated cost of early intervention services: an analysis by gestational age. | Q40236958 | ||
| Neonatal outcome following buprenorphine maintenance during conception and throughout pregnancy | Q40614437 | ||
| Transferring methadone-stabilized pregnant patients to buprenorphine using an immediate release morphine transition: an open-label exploratory study | Q42679261 | ||
| Youth retention: factors associated with treatment drop-out from youth alcohol and other drug treatment | Q43237603 | ||
| Opioid maintenance treatment during pregnancy: occurrence and severity of neonatal abstinence syndrome. A national prospective study | Q43585738 | ||
| Buprenorphine and methadone treatment of opiate dependence during pregnancy: comparison of fetal growth and neonatal outcomes in two consecutive case series | Q43813287 | ||
| From the third month of pregnancy to 1 year postpartum. Prevalence, incidence, recurrence, and new onset of depression. Results from the perinatal depression-research & screening unit study | Q43992263 | ||
| Treatment of opioid-dependent pregnant women with buprenorphine | Q44330832 | ||
| Management of neonatal abstinence syndrome in neonates born to opioid maintained women | Q44332154 | ||
| Buprenorphine in pregnant opioid-dependent women: first results of a prospective study. | Q44344412 | ||
| Assessment of opioid dependence with naloxone | Q44349145 | ||
| Buprenorphine versus methadone in the treatment of pregnant opioid-dependent patients: effects on the neonatal abstinence syndrome | Q44349294 | ||
| Substance misuse during pregnancy | Q44569096 | ||
| Buprenorphine withdrawal syndrome in newborns: a report of 13 cases | Q44654854 | ||
| Obstetric and perinatal outcomes in pregnancies associated with illicit substance abuse | Q44998949 | ||
| The impact of substance abuse treatment modality on birth weight and health care expenditures | Q45100729 | ||
| A pilot study on voucher-based incentives to promote abstinence from cigarette smoking during pregnancy and postpartum | Q46413741 | ||
| Prospective multicenter observational study of 260 infants born to 259 opiate-dependent mothers on methadone or high-dose buprenophine substitution | Q46780570 | ||
| Management of neonatal abstinence syndrome in neonatal intensive care units: a national survey. | Q46851614 | ||
| Methadone versus buprenorphine in pregnant addicts: a double-blind, double-dummy comparison study | Q46918315 | ||
| Impact of very preterm birth on health care costs at five years of age. | Q46971874 | ||
| Methadone in pregnancy: treatment retention and neonatal outcomes. | Q52290576 | ||
| Risk factors for preterm birth among opiate-addicted gravid women in a methadone treatment program. | Q52295017 | ||
| Relationship between maternal methadone dose at delivery and neonatal abstinence syndrome. | Q52296554 | ||
| Duration of methadone maintenance treatment during pregnancy and pregnancy outcome parameters in women with opiate addiction. | Q52299206 | ||
| Rating the presence and severity of opiate dependence | Q68810127 | ||
| Buprenorphine maintenance in pregnant opiate addicts | Q77393405 | ||
| P433 | issue | 1 | |
| P921 | main subject | human pregnancy | Q11995 |
| lessons learned | Q1673259 | ||
| opioid | Q427523 | ||
| P304 | page(s) | 15-24 | |
| P577 | publication date | 2012-11-13 | |
| P1433 | published in | Human Psychopharmacology | Q15751477 |
| P1476 | title | Lessons learned from a comparison of evidence-based research in pregnant opioid-dependent women | |
| P478 | volume | 28 |
| Q28073116 | Buprenorphine compared with methadone to treat pregnant women with opioid use disorder: a systematic review and meta-analysis of safety in the mother, fetus and child |
| Q24201642 | Maintenance agonist treatments for opiate-dependent pregnant women |
| Q48027117 | Monitoring neonatal abstinence syndrome in buprenorphine-exposed in vitro fertilization twins: A case study |
| Q24186643 | Psychosocial interventions for pregnant women in outpatient illicit drug treatment programs compared to other interventions |
| Q36288030 | Recent trends in treatment admissions for prescription opioid abuse during pregnancy |
| Q34999915 | Recruitment and retention of pregnant women into clinical research trials: an overview of challenges, facilitators, and best practices |
| Q38607448 | Retention in medication-assisted treatment for opiate dependence: A systematic review. |
| Q38207160 | Substance abuse/dependence treatment: a European perspective |
Search more.